MJA
MJA InSight
MJA Careers
Letters

Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little

David J Blacker
Med J Aust 2004; 180 (3): 142-143.

David J Blacker

Neurologist and Stroke Physician, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009. davidblackermdAThotmail.com

David J Blacker, Neurologist and Stroke Physician
Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009.
Article References: 
Reference Text: 
Hoffman J. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Med J Aust 2003; 179: 333-334. <eMJA full text>
Reference Order: 
1
PubMed ID: 
14503891
Reference Text: 
Donnan G, David S, Levi C. Thrombolysis for acute ischaemic stroke: revisiting the evidence. Med J Aust 2003; 179: 386-389. <eMJA full text>
Reference Order: 
2
PubMed ID: 
Reference Text: 
David S, Parsons M, Butcher K, Szoeke C. Thrombolysis for acute ischaemic stroke: revisting the evidence. Med J Aust 2003; 179: 386-389. <eMJA full text>
Reference Order: 
3
PubMed ID: 
Reference Text: 
Ingall T, O’Fallon W, Louise T, et al. Initial findings of the rt-PA acute stroke treatment review panel. Cerebrovasc Dis 2003; 16 Suppl 4: S1-S125.
Reference Order: 
4
PubMed ID: 
Reference Text: 
Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
Reference Order: 
5
PubMed ID: 
7477192

The full contents of this page are only available to subscribers.